Advertisement
Screener

IVERIC bio, Inc. Effect on Future Cash Flows, Amount

IVERIC bio, Inc. Effect on Future Cash Flows, Amount

IVERIC bio, Inc. reported Effect on Future Cash Flows, Amount of -$12.10 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-05.

Discontinued › Notes › Restructuring and Related Activities

us-gaap:EffectOnFutureCashFlowsAmount · last filed 2018-03-05

  • IVERIC bio, Inc. effect on future cash flows, amount for the quarter ending 2017-12-31 was $300.00K.
  • IVERIC bio, Inc. effect on future cash flows, amount for fiscal 2017 was -$12.10M.
Period endEffect on Future Cash Flows, Amount 3 monthEffect on Future Cash Flows, Amount 9 monthEffect on Future Cash Flows, Amount 12 month
2017-12-31$300.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-05
-$12.10M
10-K · filed 2018-03-05
2017-09-30-$12.40M
10-Q · filed 2017-11-08